Our 2025 Healthy Future Progress Report shows the steps Teva is taking for the health of people, the planet and our business.
We are all in for better health.
Our 2025 Healthy Future Report
Learn how we’re making Teva more resilient while continuing to better health worldwide
View the full report now
Creating a healthy future
4 Things You Might Not Know About Our 2025 Healthy Future Report.
Teva and Polpharma Biologics Announce Global Licensing Agreement for a Biosimilar Candidate to Ocrevus® (ocrelizumab) for Multiple Sclerosis
Report highlights
Healthy Planet
60% of electricity renewable sources
39% reducing greenhouse gas emissions from our operations since 2019
Healthy People
361.4M doses of medicine donated to patient
7.9M people reached through product donations
399,000 people helped through health systems-strengthening and capacity buildings programs
Healthy Business
99%+ of active employees trained on complience and ethics
66% of significant suppliers underwent sustainability performance evaluations
Your Privacy Choices